The Legal and Ethical Debate on Human Heritable Genome Editing (HHGE) in South Africa
By Jantina de Vries,
EthicsLab
| 11. 15. 2024
The conversation around human heritable genome editing (HHGE) in South Africa is marked by controversy and conflicting interpretations of the law. At the center of this debate lies a team of lawyers based at a South African university, who have long championed a highly liberal stance toward reproductive technologies, including HHGE. Their assertions, however, have raised significant concerns among South Africa’s legal, ethical, and scientific communities.
Is heritable human genome editing already legal in South Africa?
This team has made the controversial claim that HHGE is already legal in South Africa – a position that has gained significant national and international outrage in recent days. As a non-lawyer, I have struggled to make sense of their argument which seems highly technical. Let me try to explain what I think they are saying.
Their argument seems to hinge on a specific interpretation of the National Health Act, which prohibits genetic modification for the purposes of reproductive cloning. They seem to argue that the term "reproductive" in the law should be read to refer to the purpose of the genetic manipulation –...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...